Thrombospondins in physiology and disease: New tricks for old dogs
Open accessThe DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
Thrombospondins (TSPs) belong to a family of five, secreted, modular glycoproteins encoded by separate genes (Adams and Lawler, 2004, 2011). Group A TSPs (TSP1 and TSP2) are homotrimers, whereas group B TSPs (TSP3, -4, and -5/COMP) are homopentamers (Adams, 2001), and all are secreted as disulfide-bonded complexes. Although the five members of the TSP family differ with respect to structure, cell type, and temporal expression, all TSPs bind to components of the extracellular matrix as well as to a number of cell surface receptors, enabling TSPs to modulate cellular behaviors in a wide array of tissue contexts. TSPs are the prototype of the matricellular protein (Bornstein, 1995) and have been the subject of intense study for four decades. First identified in 1971 as protein released from thrombin-stimulated platelets, TSP1 (thrombin sensitive protein) was initially studied for its role in platelet aggregation and related hemostatic functions (Baenziger et al., 1971; Gartner and Dockter, 1984; Lahav et al., 1982; Lawler et al., 1978; Phillips et al., 1980). The eponym thrombospondin was proposed by Lawler and co-workers (Lawler et al., 1978) who isolated intact thrombospondin complexes from thrombin-treated platelets in physiological saline. Thrombospondin is a filamentous glycoprotein ~70 nm long and binds to heparin-affinity columns, and thus, to heparan sulfate proteoglycans in vivo (Fig. 1). Over the next two decades, it was discovered that TSP1 is synthesized and secreted by endothelial cells as well as other cell types in culture (Asch et al., 1986; Jaffe et al., 1982; Jaffe et al., 1985; Jaffe et al., 1983; McPherson et al., 1981; Mosher et al., 1982; Raugi and Lovett, 1987). The expression of TSP1 by diverse cell types, identification of interacting proteins, and the subsequent recognition that TSP1 binds to specific cell surface molecules in a saturable manner (Asch et al., 1987; McKeown-Longo et al., 1984; Murphy-Ullrich and Mosher, 1987; Roberts et al., 1985; Silverstein et al., 1984) provided the first evidence that TSPs might regulate cell behavior through direct interactions with cell surface receptors to activate intracellular signaling pathways: these first known receptors turned out to be CD36 (GP88) and heparan sulfate proteolgycans (syndecans) and established precedents for identification of other TSP receptors (Asch et al., 1987; Asch et al., 1992; Chung et al., 1999; Godyna et al., 1995; Goicoechea et al., 2000; Lawler and Hynes, 1989; Lawler et al., 1988; Murphy-Ullrich et al., 1988; Sun et al., 1989; Tuszynski et al., 1993; Wang and Frazier, 1998). Subsequent work showed that TSP1 expression is regulated by growth factors (PDGF, TGF-β), that TSP1 can enhance cellular responses to growth factors such as EGF, antagonize VEGF signaling, or variably regulate FGF family signaling (Gupta et al., 1999; Iruela-Arispe et al., 1999; Majack et al., 1985, 1986; Orr et al., 2003; Penttinen et al., 1988; Taraboletti et al., 1992). Elegant biochemistry, protein structural studies, and cloning and sequencing of the TSP1 gene further elucidated relationships between discrete modular domains of TSPs and specific cellular functions as well as regulators of gene expression (Bornstein et al., 1990; Dixit et al., 1986; Frazier et al., 1987; Lawler, 1986; Slane et al., 1988; Sun and Mosher, 1991). Together these early findings stimulated many diverse and fruitful avenues of investigation which have yielded surprising insights into the diverse functions of this remarkable family of proteins. Fig. 1 Model of TSP1 monomer showing the N-terminal laminin G-like domain, the oligomerization region of interchain disulfide bonding, the procolllagen-like, von Willebrand factor_C module, the properdin-like type 1 (TSR) repeats, the EGF-like repeats, and the ... This thematic series of interrelated mini-reviews will focus on recent additions to the armamentarium of TSP functions. The review by Mosher and Adams (2012, this issue) employs both evolutionary and structural perspectives to discern the functions of thrombospondins as well as other matricellular proteins, especially in the context of the complex network of intermolecular interactions occurring in the extracellular matrix and at the cell surface. The review by Roberts and co-workers (2012, this issue) highlights the role of TSP1 as a regulator of local and systemic physiology through its ability to attenuate nitric oxide signaling. The identification of TSP1 as a regulator of nitric oxide signaling has significantly broadened our understanding of the role of TSP1, especially in vascular physiology and pathology. The review by Risher and Eroglu (2012, this issue) discusses exciting, novel findings documenting a role for TSP in synaptogenesis through interactions between astrocyte-secreted TSPs and their neuronal receptor, calcium channel subunit α2δ-1, also a receptor for gabapentin. Collectively, these new findings have implications for neuronal development and responses to CNS injury. Finally, Sweetwyne and Murphy-Ullrich (2012, this issue) focus on distinct roles for TSP1 mediated by different domains which impact basic cellular processes key for wound healing, tissue repair, and fibrosis. These entail stimulation of collagen expression through the N-terminal domain calreticulin-binding sequence, transactivation of EGF receptor by the EGF-like domains, and regulation of latent TGF-β activation by the TSR type 1 repeats. Many of these findings were initially presented at the 2010 FASEB Summer Research Conference on Thrombospondins and Other Matricellular Proteins in Tissue Organization and Homeostasis. Clearly, despite several decades of research, the thrombospondins continue to surprise us with their broad and clinically-significant roles in physiology and disease. The field of matrix biology has been enriched by the often unexpected roles of thrombospondins in normal development and physiology and in the pathophysiology of diverse disease processes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Diversity of function is inherent in matricellular proteins: an appraisal of thrombospondin 1.
Bornstein, P. (1995) · The Journal of cell biology · doi:10.1083/jcb.130.3.503 · Cited by 666
Cited by
Proteoglycan form and function: A comprehensive nomenclature of proteoglycans
Iozzo, R. V., & Schaefer, L. (2015) · Matrix Biology · doi:10.1016/j.matbio.2015.02.003 · Cited by 1,263
Self-citationHalper, J., & Kjaer, M. (2014) · Advances in Experimental Medicine and Biology · doi:10.1007/978-94-007-7893-1_3 · Cited by 532
Thrombospondin-1 regulation of latent TGF-β activation: A therapeutic target for fibrotic disease
Murphy-Ullrich, J. E., & Suto, M. J. (2018) · Matrix Biology · doi:10.1016/j.matbio.2017.12.009 · Cited by 332
Self-citationGubbiotti, M. A., Vallet, S. D., Ricard-Blum, S., & Iozzo, R. V. (2016) · Matrix Biology · doi:10.1016/j.matbio.2016.09.009 · Cited by 227
Self-citationSecreted Thrombospondin-1 Regulates Macrophage Interleukin-1β Production and Activation through CD47
Stein, E. V., Miller, T. W., Ivins-O’Keefe, K., Kaur, S., & Roberts, D. D. (2016) · Scientific Reports · doi:10.1038/srep19684 · Cited by 115
Miller, T. W., Kaur, S., Ivins-O'Keefe, K., & Roberts, D. D. (2013) · Matrix Biology · doi:10.1016/j.matbio.2013.02.009 · Cited by 109
Metadata
- Authors
- Murphy-Ullrich, J. E., & Iozzo, R. V.
- Venue
- Matrix Biology
- Publisher
- Elsevier BV
- Published
- 2012-04
- Volume
- 31
- Issue
- 3
- Pages
- 152-154
- ISSN
- 0945-053X (ISSN-L)
- OpenAlex
- W2040907586
- Cited by
- 51
- References
- 1
- FWCI
- 2.78
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.